The Global Familial Hypercholesterolemia Treatment Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Familial hypercholesterolemia is a genetic disorder caused by increased levels of LDL, or low-density lipoprotein, in blood vessels. Populations suffering from familial hypercholesterolemia are expected to have a higher risk of heart risk and later […]
